| Product Type | TABLET |
| Pack Size | 10T |
| Composition | Glimepiride 2 mg + Metformin HCL 500 mg + Voglibose 0.2 mg |
| Therapeutic Use | 1. Reduces fasting blood glucose (FBG). 2. Controls postprandial blood glucose (PPBG). 3. Lowers HbA1c. 4. May delay the progression of diabetic complications by maintaining better long-term glucose control. |
Seamark
Aspire to Serve Humanity
